Researchers spot whose cognitive ability may shift during dementia trials
By
Kristen Fischer
Jan 17, 2024
People who changed cognitive status from impaired to normal during clinical trials tend to be younger, have better cognition and be negative for amyloid biomarkers, according to a new study.